 Stacie Daugherty
Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension | 12 | 2024 | 1299 | 2.460 |
Why?
| | Out-of-Hospital Cardiac Arrest | 6 | 2024 | 73 | 2.240 |
Why?
| | Healthcare Disparities | 11 | 2021 | 661 | 1.960 |
Why?
| | Antihypertensive Agents | 8 | 2021 | 495 | 1.880 |
Why?
| | Sex Factors | 23 | 2024 | 2060 | 1.840 |
Why?
| | Cardiopulmonary Resuscitation | 6 | 2024 | 251 | 1.810 |
Why?
| | Medication Adherence | 5 | 2022 | 489 | 1.450 |
Why?
| | Exercise Test | 5 | 2017 | 617 | 1.290 |
Why?
| | Myocardial Infarction | 11 | 2017 | 1046 | 1.150 |
Why?
| | Cardiology | 7 | 2024 | 271 | 1.130 |
Why?
| | Racism | 4 | 2021 | 143 | 0.930 |
Why?
| | Registries | 20 | 2022 | 2048 | 0.900 |
Why?
| | Heart Failure | 8 | 2022 | 2046 | 0.850 |
Why?
| | Cardiovascular Diseases | 7 | 2024 | 2115 | 0.840 |
Why?
| | Practice Guidelines as Topic | 4 | 2019 | 1543 | 0.830 |
Why?
| | Coronary Disease | 3 | 2011 | 371 | 0.820 |
Why?
| | Blood Pressure | 5 | 2019 | 1786 | 0.770 |
Why?
| | Social Values | 2 | 2021 | 37 | 0.760 |
Why?
| | Risk Assessment | 7 | 2022 | 3446 | 0.730 |
Why?
| | Defibrillators, Implantable | 6 | 2019 | 304 | 0.690 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 5 | 2018 | 195 | 0.690 |
Why?
| | Cardiologists | 2 | 2018 | 44 | 0.690 |
Why?
| | Multimodal Imaging | 5 | 2024 | 112 | 0.660 |
Why?
| | Myocardial Ischemia | 3 | 2022 | 255 | 0.630 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2020 | 75 | 0.630 |
Why?
| | United States | 33 | 2025 | 14945 | 0.590 |
Why?
| | Adrenergic beta-Antagonists | 5 | 2018 | 221 | 0.590 |
Why?
| | Public Opinion | 1 | 2019 | 66 | 0.590 |
Why?
| | Death, Sudden, Cardiac | 4 | 2015 | 183 | 0.590 |
Why?
| | Primary Prevention | 4 | 2015 | 195 | 0.580 |
Why?
| | Patient Acceptance of Health Care | 1 | 2025 | 843 | 0.570 |
Why?
| | Attitude to Health | 1 | 2021 | 452 | 0.560 |
Why?
| | Radiography, Thoracic | 1 | 2019 | 165 | 0.560 |
Why?
| | Middle Aged | 34 | 2025 | 33226 | 0.560 |
Why?
| | Female | 55 | 2025 | 73002 | 0.560 |
Why?
| | Clinical Decision-Making | 2 | 2018 | 324 | 0.560 |
Why?
| | Risk Factors | 18 | 2025 | 10363 | 0.550 |
Why?
| | Male | 49 | 2025 | 67386 | 0.540 |
Why?
| | Humans | 70 | 2025 | 136965 | 0.510 |
Why?
| | Thromboembolism | 1 | 2017 | 116 | 0.500 |
Why?
| | Warfarin | 1 | 2017 | 154 | 0.500 |
Why?
| | Atrial Fibrillation | 2 | 2018 | 377 | 0.500 |
Why?
| | Anemia | 1 | 2017 | 171 | 0.500 |
Why?
| | Disease Management | 2 | 2019 | 615 | 0.490 |
Why?
| | Sleep Wake Disorders | 1 | 2020 | 300 | 0.490 |
Why?
| | Hospitalization | 3 | 2025 | 2182 | 0.490 |
Why?
| | Anticoagulants | 2 | 2018 | 652 | 0.490 |
Why?
| | Follow-Up Studies | 13 | 2022 | 5048 | 0.480 |
Why?
| | Patient Discharge | 5 | 2022 | 901 | 0.480 |
Why?
| | Hemoglobins | 1 | 2017 | 352 | 0.470 |
Why?
| | Coronary Artery Disease | 5 | 2022 | 698 | 0.460 |
Why?
| | Ultrasonography | 1 | 2019 | 761 | 0.450 |
Why?
| | Stroke | 4 | 2024 | 1124 | 0.450 |
Why?
| | Percutaneous Coronary Intervention | 3 | 2017 | 482 | 0.440 |
Why?
| | Sleep | 2 | 2022 | 788 | 0.440 |
Why?
| | Aged | 26 | 2024 | 23803 | 0.430 |
Why?
| | Quality of Health Care | 2 | 2020 | 648 | 0.430 |
Why?
| | American Heart Association | 5 | 2020 | 301 | 0.430 |
Why?
| | Practice Patterns, Physicians' | 3 | 2018 | 1295 | 0.420 |
Why?
| | Ambulatory Care | 1 | 2018 | 567 | 0.410 |
Why?
| | Guideline Adherence | 1 | 2018 | 550 | 0.410 |
Why?
| | Emergency Service, Hospital | 1 | 2025 | 2080 | 0.410 |
Why?
| | Sex Distribution | 5 | 2020 | 373 | 0.410 |
Why?
| | Hemostasis, Surgical | 1 | 2013 | 22 | 0.400 |
Why?
| | Blood Loss, Surgical | 1 | 2013 | 99 | 0.380 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2017 | 451 | 0.380 |
Why?
| | Postoperative Hemorrhage | 1 | 2013 | 83 | 0.380 |
Why?
| | Aged, 80 and over | 10 | 2021 | 7559 | 0.370 |
Why?
| | Health Status Disparities | 3 | 2021 | 297 | 0.370 |
Why?
| | Drug Resistance | 1 | 2012 | 145 | 0.360 |
Why?
| | Alaska Natives | 2 | 2022 | 150 | 0.310 |
Why?
| | Patient Selection | 2 | 2013 | 685 | 0.310 |
Why?
| | Resuscitation Orders | 2 | 2020 | 43 | 0.300 |
Why?
| | Adult | 20 | 2025 | 37715 | 0.300 |
Why?
| | Patient Preference | 1 | 2011 | 197 | 0.300 |
Why?
| | Multivariate Analysis | 4 | 2017 | 1484 | 0.280 |
Why?
| | Electrocardiography | 1 | 2011 | 607 | 0.280 |
Why?
| | Incidence | 7 | 2022 | 2793 | 0.270 |
Why?
| | Societies, Medical | 4 | 2024 | 811 | 0.270 |
Why?
| | Cardiac Catheterization | 1 | 2011 | 512 | 0.270 |
Why?
| | Cohort Studies | 7 | 2025 | 5688 | 0.250 |
Why?
| | Aspirin | 2 | 2017 | 389 | 0.250 |
Why?
| | Coronary Angiography | 1 | 2008 | 314 | 0.250 |
Why?
| | Lung | 1 | 2019 | 4035 | 0.240 |
Why?
| | Indians, North American | 2 | 2022 | 655 | 0.240 |
Why?
| | Thoracic Surgery | 2 | 2017 | 132 | 0.240 |
Why?
| | Retrospective Studies | 14 | 2024 | 15536 | 0.240 |
Why?
| | Heart Diseases | 2 | 2019 | 325 | 0.240 |
Why?
| | Continuity of Patient Care | 1 | 2008 | 282 | 0.240 |
Why?
| | Heart Arrest | 2 | 2020 | 336 | 0.230 |
Why?
| | Young Adult | 11 | 2024 | 13218 | 0.230 |
Why?
| | Insurance, Health | 2 | 2025 | 287 | 0.220 |
Why?
| | Heart-Assist Devices | 2 | 2022 | 545 | 0.220 |
Why?
| | Touch Perception | 1 | 2024 | 18 | 0.210 |
Why?
| | Secondary Prevention | 2 | 2017 | 234 | 0.210 |
Why?
| | Health Knowledge, Attitudes, Practice | 3 | 2024 | 1365 | 0.210 |
Why?
| | Prospective Studies | 7 | 2019 | 7512 | 0.200 |
Why?
| | Housing | 1 | 2024 | 144 | 0.200 |
Why?
| | Odds Ratio | 5 | 2017 | 1071 | 0.190 |
Why?
| | Migraine Disorders | 1 | 2024 | 103 | 0.190 |
Why?
| | Prognosis | 6 | 2019 | 3931 | 0.190 |
Why?
| | Intention to Treat Analysis | 1 | 2021 | 74 | 0.180 |
Why?
| | Peptide Fragments | 2 | 2017 | 690 | 0.180 |
Why?
| | Single-Blind Method | 1 | 2021 | 280 | 0.170 |
Why?
| | Self Report | 2 | 2022 | 836 | 0.170 |
Why?
| | Hospital Mortality | 4 | 2018 | 895 | 0.170 |
Why?
| | Women's Health | 2 | 2016 | 374 | 0.170 |
Why?
| | Professional-Patient Relations | 1 | 2021 | 151 | 0.170 |
Why?
| | Writing | 1 | 2021 | 98 | 0.160 |
Why?
| | Treatment Outcome | 10 | 2017 | 10664 | 0.160 |
Why?
| | Telephone | 1 | 2021 | 179 | 0.160 |
Why?
| | Sex Characteristics | 5 | 2022 | 766 | 0.160 |
Why?
| | Drug Therapy, Combination | 2 | 2019 | 1022 | 0.150 |
Why?
| | Survival Rate | 5 | 2020 | 1882 | 0.150 |
Why?
| | Cardiac Resynchronization Therapy Devices | 1 | 2019 | 9 | 0.150 |
Why?
| | Electric Countershock | 1 | 2019 | 101 | 0.150 |
Why?
| | Sexuality | 1 | 2019 | 31 | 0.150 |
Why?
| | Oropharyngeal Neoplasms | 1 | 2019 | 53 | 0.150 |
Why?
| | Prevalence | 3 | 2024 | 2732 | 0.150 |
Why?
| | Colorado | 3 | 2021 | 4542 | 0.140 |
Why?
| | Clinical Audit | 1 | 2018 | 13 | 0.140 |
Why?
| | Congresses as Topic | 1 | 2020 | 225 | 0.140 |
Why?
| | Ventricular Function | 1 | 2018 | 54 | 0.140 |
Why?
| | Heart Failure, Diastolic | 1 | 2018 | 21 | 0.140 |
Why?
| | Time Factors | 6 | 2018 | 6786 | 0.140 |
Why?
| | Heart Failure, Systolic | 1 | 2018 | 24 | 0.140 |
Why?
| | Logistic Models | 4 | 2012 | 2066 | 0.140 |
Why?
| | Predictive Value of Tests | 3 | 2019 | 1999 | 0.140 |
Why?
| | Postmenopause | 1 | 2020 | 367 | 0.140 |
Why?
| | F Factor | 1 | 2017 | 3 | 0.140 |
Why?
| | Atherosclerosis | 1 | 2022 | 414 | 0.140 |
Why?
| | Positron-Emission Tomography | 1 | 2019 | 291 | 0.140 |
Why?
| | Patient Readmission | 2 | 2020 | 699 | 0.140 |
Why?
| | Residence Characteristics | 1 | 2020 | 366 | 0.130 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 2 | 2017 | 38 | 0.130 |
Why?
| | Ezetimibe | 1 | 2017 | 24 | 0.130 |
Why?
| | Transgender Persons | 1 | 2020 | 188 | 0.130 |
Why?
| | Simvastatin | 1 | 2017 | 60 | 0.130 |
Why?
| | Health Care Surveys | 1 | 2019 | 564 | 0.130 |
Why?
| | Point-of-Care Systems | 1 | 2019 | 178 | 0.130 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2017 | 97 | 0.130 |
Why?
| | Poverty | 1 | 2020 | 522 | 0.130 |
Why?
| | Anesthesiology | 1 | 2017 | 86 | 0.130 |
Why?
| | Chi-Square Distribution | 1 | 2017 | 521 | 0.120 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2017 | 102 | 0.120 |
Why?
| | Heart Valve Diseases | 1 | 2017 | 149 | 0.120 |
Why?
| | Sex Offenses | 1 | 2019 | 197 | 0.120 |
Why?
| | Mortality | 2 | 2008 | 356 | 0.120 |
Why?
| | Blood Pressure Determination | 2 | 2014 | 160 | 0.120 |
Why?
| | Anticholesteremic Agents | 1 | 2017 | 154 | 0.120 |
Why?
| | Diagnostic Imaging | 1 | 2017 | 329 | 0.110 |
Why?
| | Administration, Oral | 1 | 2017 | 783 | 0.110 |
Why?
| | Aortic Valve Stenosis | 1 | 2017 | 228 | 0.110 |
Why?
| | Waiting Lists | 1 | 2017 | 258 | 0.110 |
Why?
| | Ambulatory Care Facilities | 2 | 2020 | 243 | 0.110 |
Why?
| | Communication | 2 | 2018 | 911 | 0.110 |
Why?
| | Angiography | 3 | 2020 | 206 | 0.100 |
Why?
| | Acute Coronary Syndrome | 1 | 2017 | 279 | 0.100 |
Why?
| | Decision Support Techniques | 1 | 2017 | 420 | 0.100 |
Why?
| | Referral and Consultation | 1 | 2019 | 779 | 0.100 |
Why?
| | Hirudins | 1 | 2013 | 49 | 0.100 |
Why?
| | Heart Defects, Congenital | 1 | 2020 | 828 | 0.100 |
Why?
| | Critical Care | 1 | 2018 | 599 | 0.100 |
Why?
| | Obesity | 2 | 2024 | 3023 | 0.100 |
Why?
| | Antithrombins | 1 | 2013 | 59 | 0.100 |
Why?
| | Hemorrhage | 1 | 2017 | 717 | 0.100 |
Why?
| | Medicaid | 1 | 2017 | 437 | 0.100 |
Why?
| | Diuretics | 1 | 2012 | 70 | 0.090 |
Why?
| | Depression | 1 | 2021 | 1454 | 0.090 |
Why?
| | Echocardiography | 3 | 2020 | 639 | 0.090 |
Why?
| | Health Personnel | 1 | 2018 | 729 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2013 | 2015 | 0.090 |
Why?
| | Stroke Volume | 1 | 2013 | 571 | 0.080 |
Why?
| | Heart Transplantation | 1 | 2017 | 687 | 0.080 |
Why?
| | Aftercare | 2 | 2022 | 208 | 0.080 |
Why?
| | Recombinant Proteins | 1 | 2013 | 1343 | 0.080 |
Why?
| | Age Factors | 4 | 2022 | 3258 | 0.080 |
Why?
| | Biomarkers | 2 | 2017 | 4095 | 0.080 |
Why?
| | Hospitals | 1 | 2014 | 689 | 0.080 |
Why?
| | Eligibility Determination | 1 | 2009 | 69 | 0.080 |
Why?
| | Medicare | 3 | 2022 | 785 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 4 | 2020 | 2654 | 0.070 |
Why?
| | Poisson Distribution | 1 | 2008 | 76 | 0.070 |
Why?
| | Proportional Hazards Models | 2 | 2008 | 1251 | 0.070 |
Why?
| | Pregnancy | 1 | 2020 | 6736 | 0.070 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5530 | 0.070 |
Why?
| | Magnetic Resonance Imaging, Cine | 2 | 2017 | 193 | 0.060 |
Why?
| | Regression Analysis | 1 | 2008 | 1007 | 0.060 |
Why?
| | Veterans | 1 | 2017 | 1477 | 0.060 |
Why?
| | Longitudinal Studies | 1 | 2012 | 2851 | 0.060 |
Why?
| | Heart Rate | 1 | 2008 | 794 | 0.060 |
Why?
| | Recovery of Function | 1 | 2008 | 648 | 0.050 |
Why?
| | Adolescent | 6 | 2022 | 21471 | 0.050 |
Why?
| | Evidence-Based Medicine | 1 | 2008 | 735 | 0.050 |
Why?
| | Primary Health Care | 1 | 2014 | 1775 | 0.050 |
Why?
| | Pilot Projects | 2 | 2020 | 1730 | 0.050 |
Why?
| | Surgical Procedures, Operative | 1 | 2024 | 258 | 0.050 |
Why?
| | Alaska | 1 | 2021 | 83 | 0.040 |
Why?
| | Risk Reduction Behavior | 1 | 2022 | 216 | 0.040 |
Why?
| | Cholesterol | 1 | 2022 | 411 | 0.040 |
Why?
| | Gender Identity | 1 | 2020 | 124 | 0.040 |
Why?
| | Age Distribution | 1 | 2020 | 388 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2024 | 5812 | 0.040 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2014 | 2553 | 0.040 |
Why?
| | Perception | 1 | 2021 | 365 | 0.040 |
Why?
| | Minority Health | 1 | 2018 | 20 | 0.040 |
Why?
| | SEER Program | 1 | 2019 | 227 | 0.040 |
Why?
| | Hospitals, Rural | 1 | 2018 | 42 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2020 | 613 | 0.030 |
Why?
| | California | 1 | 2019 | 437 | 0.030 |
Why?
| | Hospitals, Urban | 1 | 2018 | 137 | 0.030 |
Why?
| | Advisory Committees | 1 | 2019 | 217 | 0.030 |
Why?
| | Risk Adjustment | 1 | 2017 | 78 | 0.030 |
Why?
| | Postoperative Complications | 1 | 2009 | 2622 | 0.030 |
Why?
| | Exercise | 1 | 2008 | 2064 | 0.030 |
Why?
| | Europe | 1 | 2017 | 403 | 0.030 |
Why?
| | Needs Assessment | 1 | 2019 | 380 | 0.030 |
Why?
| | Prosthesis Design | 1 | 2018 | 329 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2024 | 3556 | 0.030 |
Why?
| | Medically Uninsured | 1 | 2017 | 132 | 0.030 |
Why?
| | Consensus | 1 | 2019 | 675 | 0.030 |
Why?
| | Body Mass Index | 1 | 2024 | 2416 | 0.030 |
Why?
| | Veterans Health | 1 | 2017 | 185 | 0.030 |
Why?
| | Insurance Coverage | 1 | 2017 | 231 | 0.030 |
Why?
| | Frail Elderly | 1 | 2015 | 130 | 0.030 |
Why?
| | Survival Analysis | 1 | 2017 | 1278 | 0.030 |
Why?
| | Linear Models | 1 | 2017 | 857 | 0.030 |
Why?
| | Caregivers | 1 | 2022 | 903 | 0.030 |
Why?
| | Radial Artery | 1 | 2014 | 68 | 0.030 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 309 | 0.030 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2017 | 465 | 0.020 |
Why?
| | Physician-Patient Relations | 1 | 2018 | 577 | 0.020 |
Why?
| | United States Department of Veterans Affairs | 1 | 2017 | 680 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2017 | 1019 | 0.020 |
Why?
| | Comorbidity | 1 | 2017 | 1626 | 0.020 |
Why?
| | Intensive Care Units | 1 | 2018 | 836 | 0.020 |
Why?
| | Dementia | 1 | 2015 | 264 | 0.020 |
Why?
| | Cholesterol, LDL | 1 | 2014 | 372 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3266 | 0.020 |
Why?
| | Qualitative Research | 1 | 2018 | 1428 | 0.020 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2014 | 281 | 0.020 |
Why?
| | Attitude of Health Personnel | 1 | 2018 | 1154 | 0.020 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2015 | 618 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2014 | 1310 | 0.020 |
Why?
| | Obstetrics | 1 | 2011 | 168 | 0.020 |
Why?
| | Gynecology | 1 | 2011 | 173 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 1027 | 0.020 |
Why?
| | Diabetes Mellitus | 1 | 2015 | 1056 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 3574 | 0.020 |
Why?
| | Cause of Death | 1 | 2008 | 428 | 0.020 |
Why?
| | Insulin | 1 | 2014 | 2394 | 0.010 |
Why?
| | Child | 1 | 2020 | 21760 | 0.010 |
Why?
| | Neoplasms | 1 | 2015 | 2698 | 0.010 |
Why?
|
|
Daugherty's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|